These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22096900)

  • 41. Hepatitis C virus and the immune system: a concise review.
    Gremion C; Cerny A
    Rev Med Virol; 2005; 15(4):235-68. PubMed ID: 15782389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection.
    Jeong HY; Lee YJ; Seo SK; Lee SW; Park SJ; Lee JN; Sohn HS; Yao S; Chen L; Choi I
    J Leukoc Biol; 2008 Mar; 83(3):755-64. PubMed ID: 18086898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
    D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
    J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Host factors involved in the replication of hepatitis C virus.
    Moriishi K; Matsuura Y
    Rev Med Virol; 2007; 17(5):343-54. PubMed ID: 17563922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines.
    Kondo Y; Sung VM; Machida K; Liu M; Lai MM
    Virology; 2007 Apr; 361(1):161-73. PubMed ID: 17175001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural killer cells in viral hepatitis: facts and controversies.
    Mondelli MU; Varchetta S; Oliviero B
    Eur J Clin Invest; 2010 Sep; 40(9):851-63. PubMed ID: 20597961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pretransplantation CD56(+) innate lymphocyte populations associated with severity of hepatitis C virus recurrence.
    Rosen HR; Doherty DG; Madrigal-Estebas L; O'Farrelly C; Golden-Mason L
    Liver Transpl; 2008 Jan; 14(1):31-40. PubMed ID: 18161829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.
    Brady MT; MacDonald AJ; Rowan AG; Mills KH
    Eur J Immunol; 2003 Dec; 33(12):3448-57. PubMed ID: 14635055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased T and B Regulatory Cell Function Contributes to the Persistence of HCV and Other Viral Infections.
    Eiza N; Toubi E; Vadasz Z
    Isr Med Assoc J; 2016; 18(3-4):159-61. PubMed ID: 27228634
    [No Abstract]   [Full Text] [Related]  

  • 50. Viral hepatitis: Subinfectious HCV exposure.
    Leake I
    Nat Rev Gastroenterol Hepatol; 2014 Jan; 11(1):4. PubMed ID: 24296578
    [No Abstract]   [Full Text] [Related]  

  • 51. Dendritic cells--the link between innate and adaptive immunity in allergy.
    Jakob T; Traidl-Hoffmann C; Behrendt H
    Curr Allergy Asthma Rep; 2002 Mar; 2(2):93-5. PubMed ID: 11892099
    [No Abstract]   [Full Text] [Related]  

  • 52. [The factors leading hepatitis C to chronicnization].
    Fan WM; Zhu WF
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):436-8. PubMed ID: 12890353
    [No Abstract]   [Full Text] [Related]  

  • 53. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
    Gonzalez VD; Landay AL; Sandberg JK
    Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mechanism of HCV persistence].
    Hiroishi K; Ishii S; Imawari M
    Nihon Rinsho; 2011 May; 69 Suppl 4():92-6. PubMed ID: 22096900
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG; Brenndörfer ED; Häussinger D
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HCV immunopathogenesis: virus-induced strategies against host immunity.
    Szabo G; Dolganiuc A
    Clin Liver Dis; 2006 Nov; 10(4):753-71. PubMed ID: 17164116
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.